The X-linked retinopathies: Physiological insights, pathogenic mechanisms, phenotypic features and novel therapies.
Samantha R De Silva, Gavin Arno, Anthony G Robson...
https://pubmed.ncbi.nlm.nih.gov/32860923/Actively Recruiting
Led by University College, London · Updated on 2026-10-28
4887
Participants Needed
3
Research Sites
N/A
Total Duration
Researchers are studying inherited retinal degeneration IRD in children and adolescents, focusing on forms caused by mutations in the RPE65 and RPGR genes. This observational study aims to develop and train artificial intelligence AI algorithms using ultra-widefield retinal imaging to identify and monitor these genetic retinal diseases. The goal is to improve early detection, track disease progression, and support evaluation of emerging treatments. Participants include those with genetically or clinically confirmed RPE65- or RPGR-associated retinal degeneration, as well as control groups without IRD, including both myopic and non-myopic individuals. Retinal images will be collected using advanced imaging devices like Optos, Zeiss-Clarus, and Heidelberg Engineering scanners. The study leverages AI to analyze these images for distinguishing affected patients and quantifying retinal changes over time. During the study, participants will provide retinal imaging data, which researchers will use to train and test AI algorithms for diagnosis accuracy and longitudinal monitoring of retinal abnormalities. The study will assess the performance of these AI tools up to one year after study completion. Participants retinal images must be of sufficient quality for analysis, and the study includes individuals up to 50 years old from diverse backgrounds.
CONDITIONS
Monitoring and Early Detection of Treatable Inherited RETinal Disease in Children and Adolescents
N
Nikolas Pontikos, PhD, MSci, MEng, FBCS
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University College, London
Lead Sponsor
Moorfields Eye Hospital NHS Foundation Trust
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit
Duration - Up to approximately 1 year after study completion
Participants undergo ultra-widefield retinal imaging using specialized devices to provide images for AI algorithm development and monitoring retinal changes over time.
Multiple imaging sessions as scheduled
Duration - Up to approximately 1 year after study completion
Researchers analyze the retinal images using AI algorithms to assess diagnosis accuracy and monitor disease progression. Participants may have follow-up imaging to track retinal changes.
Scheduled follow-up visits as needed
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Have more questions? Get in touch with our team for quick support
Samantha R De Silva, Gavin Arno, Anthony G Robson...
https://pubmed.ncbi.nlm.nih.gov/32860923/German Pinedo-Diaz, Birgit Lorenz, Sandrine H Künzel...
https://pubmed.ncbi.nlm.nih.gov/39745677/Birgit Lorenz
https://pubmed.ncbi.nlm.nih.gov/39943983/Nikolas Pontikos, William A Woof, Siying Lin...
https://pubmed.ncbi.nlm.nih.gov/40567353/William A Woof, Thales A C de Guimarães, Saoud Al-Khuzaei...
https://pubmed.ncbi.nlm.nih.gov/39896422/Daniel C Chung, Mette Bertelsen, Birgit Lorenz...
https://pubmed.ncbi.nlm.nih.gov/30268864/Sandrine H Sassen, Marlene Sassmannshausen, Josua Sassen...
https://pubmed.ncbi.nlm.nih.gov/41379738/Yi-Zhong Wang, Katherine Juroch, David Geoffrey Birch
https://pubmed.ncbi.nlm.nih.gov/38135984/University College, London
Lead Sponsor
Moorfields Eye Hospital NHS Foundation Trust
Collaborating Sponsor